Home/Filings/4/0001181431-14-012421
4//SEC Filing

INVIVO THERAPEUTICS HOLDINGS CORP. 4

Accession 0001181431-14-012421

CIK 0001292519operating

Filed

Mar 11, 8:00 PM ET

Accepted

Mar 12, 6:05 PM ET

Size

8.2 KB

Accession

0001181431-14-012421

Insider Transaction Report

Form 4
Period: 2014-03-10
REYNOLDS FRANCIS
DirectorCEO, CFO10% Owner
Transactions
  • Sale

    Common Stock

    2014-03-10$2.37/sh12,500$29,6259,723,920 total
  • Sale

    Common Stock

    2014-03-11$2.31/sh12,500$28,8759,711,420 total
  • Sale

    Common Stock

    2014-03-12$2.30/sh12,500$28,7509,698,920 total
Holdings
  • Common Stock

    (indirect: By 401(k))
    23,488
Footnotes (3)
  • [F1]All sales between $2.35 - $2.44.
  • [F2]All sales between $2.31 - $2.36.
  • [F3]All sales between $2.30 - $2.31.

Issuer

INVIVO THERAPEUTICS HOLDINGS CORP.

CIK 0001292519

Entity typeoperating
IncorporatedNV

Related Parties

1
  • filerCIK 0001292519

Filing Metadata

Form type
4
Filed
Mar 11, 8:00 PM ET
Accepted
Mar 12, 6:05 PM ET
Size
8.2 KB